LSE:HLN (Haleon plc)
About HLN
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
Haleon plc (LSE: HLN) Latest News
Investing Articles
2 FTSE 100 shares I’m steering clear of in today’s market
Investing Articles
£10,000 invested in Haleon shares 1 year ago is now worth…
Investing Articles
Is the FTSE 100 becoming increasingly disconnected from the UK economy?
Investing Articles
Looking for FTSE shares to buy? Here are 2 to consider for long-term gains
Investing Articles
Just released: the 3 best growth-focused stocks to consider buying in January [PREMIUM PICKS]
Investing Articles
The Haleon share price has woken up. Should I buy the FTSE 100 stock now?
Investing Articles
Haleon’s share price leaps 3% as first-half results reveal 11% profit increase. Is it time I buy?
Investing Articles
Here’s why the Haleon share price jumped 6% higher today
Investing Articles
Here are some of the best dividend forecasts I’ve seen for 2024
Investing Articles
The Haleon share price is stuck at £3! Should I invest?
Investing Articles
Should investors buy Haleon shares after the company raised its full-year guidance?